After two decades in employee benefits, I have watched employers spend heavily to treat a condition that could often be addressed earlier through diet, exercise, and lifestyle change. The cost of that oversight shows up as preventable claims, lost productivity, and a missed chance to redesign the benefit structure itself.
The current benefits architecture is designed to treat high cholesterol, not prevent it. That misalignment quietly costs employers more than most finance teams realize.
The $10 billion blind spot
About 86 million American adults have total cholesterol above 200 mg/dL, according to CDC data. We know the connection to heart disease. Cardiovascular disease is the leading cause of death in the United States, taking about 919,000 lives in 2023 alone.
What we don't track is the prevention gap. No benefit system measures how many employees actually lowered their LDL through diet and lifestyle, or what that shift did to downstream claims.
Your PBM profits on every statin prescription. Your carrier prices premiums based on claims history, not on whether employees actually reduced their LDL through sustainable lifestyle changes. Your wellness program hands out points for completing a health risk assessment that gathers dust, then never connects that data to real behavior change or cost reduction.
We're paying for sickness while ignoring the solution sitting in plain sight.
The seven interventions your system ignores
The clinical literature identifies seven diet and lifestyle interventions with measurable effects on LDL, and almost none of them are addressed in standard benefit design:
- The portfolio diet. In a controlled trial, combining plant sterols (about 2 g per day), viscous fibers such as oat beta-glucan and psyllium, soy protein, and almonds lowered LDL by about 30%, close to the 33% reduction from 20 mg of lovastatin in the same study. Few employers integrate this approach into care management.
- Individual variation. The same diet lowers LDL far more in some people than in others, and genetics are part of the reason. Without lipid and genetic data, care programs hand everyone the same generic advice.
- Timing and consistency of intake. Emerging research links irregular eating patterns and late-night intake to worse lipid profiles. These are zero-cost changes, but they only stick with sustained engagement, which current benefit design does not support.
- Sleep. Short and irregular sleep is tied to higher cardiovascular risk in population studies, and the American Heart Association counts sleep among its core cardiovascular health measures. Most wellness programs don't track sleep quality, and most health plans don't incentivize it.
- Advanced lipid markers. Standard panels miss markers such as oxidized LDL and Lp-PLA2. Capturing that data would reveal prevention opportunities a basic screening never surfaces.
- The gut microbiome. The probiotic strain Lactobacillus reuteri NCIMB 30242 reduced LDL by 11.6% in a randomized controlled trial, alongside reduced absorption of non-cholesterol sterols. Microbiome-informed interventions still sit outside standard benefit design.
- Consistent exercise. A meta-analysis found no reliable difference in LDL or other lipids between morning and evening exercise, but regular aerobic and interval training improves the overall lipid profile, mainly by raising HDL and lowering triglycerides. A gym reimbursement that never checks attendance misses the point.
Why current systems fail
The gap comes down to incentive alignment, and it shows up in three ways:
- No financial incentive for prevention. Employees can earn wellness points for a biometric screening, but nothing converts daily preventive actions, such as taking psyllium, following a portfolio diet, or protecting sleep, into tangible, spendable rewards.
- Disconnected data systems. Even when an employee adopts these changes, no system tracks completion, verifies outcomes, and feeds that data back into renewal discussions to reduce future premiums. Employers are flying blind.
- No wealth-building feedback loop. Health actions tied to visible, compounding rewards become permanent habits more reliably than actions framed only as avoiding a future disease. Abstract, distant benefits don't drive behavior. Automatic retirement contributions and instant store rewards do.
The solution: Rewarding prevention at the systemic level
A prevention-first benefit design would include five parts:
- Personalized plans of care. AI drafts a plan from each employee's cholesterol profile, genetics, lifestyle, and labs, and a nurse practitioner and physician review it before it reaches the employee.
- Automated verification. Standardized preventive care codes confirm completion of recommended actions, from fiber supplementation to exercise adherence and sleep consistency.
- Instant financial rewards. Employees earn real, spendable dollars at the WellthCare Store™, where FSA-approved products align with their plan of care.
- Automatic wealth building. Employers commit savings to automatic retirement contributions, so every verified preventive action also becomes a wealth-building step.
- Compliance-grade recordkeeping. Every action is tracked, verified, and reportable, giving employers the data they need at renewal.
This is the Health-to-Wealth™ Benefit System, a new category of benefits built to turn prevention into automatic wealth.
The employer ROI that changes everything
When you shift from treating cholesterol to preventing it earlier, the economics change:
- Current model: pay for medication and copays, then absorb the cost of cardiac events that prevention might have avoided
- Prevention model: pay for verified daily actions and coaching, then watch claims trend down as risk factors improve
The larger unlock comes from the data engine. After six to twelve months of real preventive behavior data, you can generate a WellthCare Readiness Index™ that shows:
- Which employees may be candidates to discuss a statin adjustment with their physician, based on their own data
- What your actual pharmacy savings would be by switching to transparent, aligned PBMs
- How much you'd save by moving your overall population to self-funded coverage with proper risk management
Who still needs a statin
None of this replaces medication. The probiotic trial concluded the strain "may be useful as an adjunctive therapy for treating hypercholesterolemia," not a substitute for standard care, and the portfolio diet's controlled-trial results depend on adherence that free-living people rarely match. People with familial hypercholesterolemia, very high LDL, or established cardiovascular disease generally need lipid-lowering therapy regardless of how well they eat. A prevention-first benefit should raise adherence to both proven diet changes and prescribed medication, and it should never push an employee off a prescribed drug without their physician's sign-off. The right system identifies who can improve with lifestyle change and who cannot, and it acts accordingly.
The bottom line
High cholesterol is a clinical problem and a systemic failure of incentives at the same time. Fix the incentives, and you lower cholesterol while rebuilding health and wealth.
Prevention has been written off as soft, unmeasurable, and too complex to scale. That false narrative has cost employers billions. The science exists. The technology exists. What has been missing is a system that connects prevention to wealth creation in a way that is automatic, verifiable, and financially undeniable. WellthCare™, the first Health-to-Wealth Benefit System, delivers that by rewarding every verified preventive action with Store dollars and automatic retirement contributions, working alongside your existing plan at zero net cost.
The question is whether you can afford to keep ignoring it.